BioCardia (BCDA) CEO Peter Altman Buys 5,000 Shares

What Happened

• Peter Altman, President, CEO and a director of BioCardia, purchased 5,000 shares of BCDA on July 29, 2026. The trades were executed in the open market (transaction code P) at a weighted-average price of $0.78 per share, for a total cost of approximately $3,900. This was a direct purchase of common stock (not an option exercise or award).

Key Details

• Transaction date: 2026-07-29
• Price: weighted average $0.78 per share (individual trades ranged $0.77–$0.80; see footnote)
• Shares acquired: 5,000; Total value: ~$3,900
• Shares owned after the transaction: not specified in the provided filing
• Footnote: F1 notes the purchase was executed in multiple trades at prices between $0.77 and $0.80; the reporting person will provide per-trade details to the SEC on request
• Filing timeliness: Reported the same day (filed 2026-07-29); not indicated as late
• No 10b5-1 plan, tax withholding, gift, or derivative activity is indicated in the provided details

Context

• This was a straightforward open-market buy. The amount is modest in dollar terms (~$3.9k), so while purchases often draw attention, the size here is small relative to many executive insider buys and should be weighed with other information about the company and insider activity.